Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Kordes

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Klinische Padiatrie|April 24, 2012
Targeted therapeutics in treatment of children and young adults with solid tumors: an expert survey and review of the literatureT G P Grunewald, N Greulich, U Kontny, et al.
British Journal of Cancer|September 15, 2012
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumoursA O von Bueren, M D Bacolod, C Hagel, et al.
Bone Marrow Transplantation|January 15, 2014
High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB)M Benesch, K Bartelheim, G Fleischhack, et al.
Familial Cancer|February 3, 2021
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working GroupM C Frühwald, K Nemes, H Boztug, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Klinische Padiatrie|April 24, 2012
Targeted therapeutics in treatment of children and young adults with solid tumors: an expert survey and review of the literatureT G P Grunewald, N Greulich, U Kontny, et al.
British Journal of Cancer|September 15, 2012
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumoursA O von Bueren, M D Bacolod, C Hagel, et al.
Bone Marrow Transplantation|January 15, 2014
High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB)M Benesch, K Bartelheim, G Fleischhack, et al.
Familial Cancer|February 3, 2021
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working GroupM C Frühwald, K Nemes, H Boztug, et al.
Pageof 2